Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-25-008439
Filing Date
2025-03-19
Accepted
2025-03-19 16:33:49
Documents
5
Period of Report
2025-04-16

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A nby20250311_def14a.htm DEF 14A 595953
2 a01.jpg GRAPHIC 118814
3 a02.jpg GRAPHIC 123743
4 image1.jpg GRAPHIC 3768
5 logo.jpg GRAPHIC 3886
  Complete submission text file 0001437749-25-008439.txt   941727
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33678 | Film No.: 25753225
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)